Biogen, Inc.
(NASDAQ : BIIB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
IMMUImmunomedics, Inc. -0.29%85.0011.0%$713.21m
AMGNAmgen, Inc. 1.96%253.171.3%$672.10m
MRNAModerna, Inc. 0.32%70.750.0%$668.52m
ILMNIllumina, Inc. 0.65%307.493.5%$630.66m
NVAXNovavax, Inc. 0.49%108.4896.5%$608.25m
GILDGilead Sciences, Inc. 1.44%63.001.0%$586.65m
REGNRegeneron Pharmaceuticals, Inc. -2.71%558.082.7%$427.11m
BIIBBiogen, Inc. -0.14%281.971.6%$350.33m
VRTXVertex Pharmaceuticals, Inc. 0.28%271.071.9%$346.99m
SRNESorrento Therapeutics, Inc. -4.44%11.091.5%$306.67m
ALXNAlexion Pharmaceuticals, Inc. 1.13%113.732.0%$283.10m
EXASEXACT Sciences Corp. 0.08%102.0920.7%$271.77m
SGENSeattle Genetics, Inc. 2.64%196.006.0%$233.45m
VXRTVaxart, Inc. -2.83%6.630.0%$192.03m
MNTAMomenta Pharmaceuticals, Inc. -0.01%52.493.0%$177.06m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.